← Leaderboards
Robert David Schreiber
Washington University
$32,299,425
Attributed
$35,788,076
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,101,625 · 17
By mechanism
R01$13,239,452 · 5
T32$12,663,927 · 2
P01$4,910,639 · 2
U01$3,822,359 · 1
P30$2,472,199 · 4
U54$1,821,696 · 1
Top collaborators
- Robert D Cardiff5 shared
- William E Gillanders5 shared
Most similar at Washington University
Same institution · by research overlap
- Andrey S. Shaw$11,736,578
- William E Gillanders$14,751,159
- Marco Colonna$45,277,211
- Pengyuan Liu$3,655,052
- Haris G. Vikis$512,517
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseTumorMalignant NeoplasmsLaboratoriesProteinsImmune ResponseImmuneT-LymphocyteCellsMacrophageMolecularImmune SystemTissuesMouse ModelCancer BiologyTrainingTumor AntigensLaboratory MouseCytokineGrowthResponseImmunotherapyProgramsMember
Grant awards (98)
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER$343,165
T32 · FY2025 · CA · contact PI
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER$416,112
T32 · FY2024 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$625,110
R01 · FY2023 · CA
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER$379,475
T32 · FY2023 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$625,095
R01 · FY2022 · CA
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER$394,366
T32 · FY2022 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$637,864
R01 · FY2021 · CA
Targeting Neoantigens in Triple Negative Breast Cancer$637,836
R01 · FY2020 · CA
Training in Cancer Biology$530,056
T32 · FY2020 · CA · contact PI
Targeting Neoantigens in Triple Negative Breast Cancer$629,038
R01 · FY2019 · CA
Training in Cancer Biology$598,865
T32 · FY2019 · CA · contact PI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY$372,200
R01 · FY2019 · CA · contact PI
Training in Cancer Biology$535,845
T32 · FY2018 · CA · contact PI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY$383,713
R01 · FY2018 · CA · contact PI
Training in Cancer Biology$553,181
T32 · FY2017 · CA · contact PI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY$456,897
R01 · FY2017 · CA · contact PI
Training in Cancer Biology$12,861
T32 · FY2017 · CA · contact PI
Training in Cancer Biology$520,900
T32 · FY2016 · CA · contact PI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY$448,985
R01 · FY2016 · CA · contact PI
Training in Cancer Biology$493,819
T32 · FY2015 · CA · contact PI
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY$469,115
R01 · FY2015 · CA · contact PI
Genetics Core$266,435
P30 · FY2015 · AR · contact PI
Training in Cancer Biology$593,659
T32 · FY2014 · CA · contact PI
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING$337,116
R01 · FY2014 · CA · contact PI
Genetics Core$243,702
P30 · FY2014 · AR · contact PI
Tumor Immunology Program$61,006
P30 · FY2014 · CA · contact PI
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance$673,059
U01 · FY2013 · CA · contact PI
Training in Cancer Biology$583,887
T32 · FY2013 · CA · contact PI
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path$367,760
U54 · FY2013 · AI · contact PI
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING$329,891
R01 · FY2013 · CA · contact PI
Genetics Core$253,116
P30 · FY2013 · AR · contact PI
Tumor Immunology Program$60,204
P30 · FY2013 · CA · contact PI
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance$743,032
U01 · FY2012 · CA · contact PI
Training in Cancer Biology$556,168
T32 · FY2012 · CA · contact PI
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path$356,418
U54 · FY2012 · AI · contact PI
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING$354,390
R01 · FY2012 · CA · contact PI
Genetics Core$233,551
P30 · FY2012 · AR · contact PI
Tumor Immunology Program$62,816
P30 · FY2012 · CA · contact PI
Tumor Immunology Program$2,779
P30 · FY2012 · CA · contact PI
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance$761,090
U01 · FY2011 · CA · contact PI
Training in Cancer Biology$396,471
T32 · FY2011 · CA · contact PI
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path$362,291
U54 · FY2011 · AI · contact PI
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING$357,864
R01 · FY2011 · CA · contact PI
Core B - Genetics Core$343,447
P30 · FY2011 · AR · contact PI
Tumor Immunology Program$7,480
P30 · FY2011 · CA · contact PI
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance$820,178
U01 · FY2010 · CA · contact PI
Training in Cancer Biology$402,831
T32 · FY2010 · CA · contact PI
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING$380,000
R01 · FY2010 · CA · contact PI
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path$375,843
U54 · FY2010 · AI · contact PI
Genetic Core$209,817
P30 · FY2010 · AR · contact PI
Tumor Immunology Program$7,864
P30 · FY2010 · CA · contact PI
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast Cance$825,000
U01 · FY2009 · CA · contact PI
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path$359,384
U54 · FY2009 · AI · contact PI
Training in Cancer Biology$322,249
T32 · FY2009 · CA · contact PI
Genetic Core$209,817
P30 · FY2009 · AR · contact PI
Training in Cancer Biology$509,782
T32 · FY2008 · CA · contact PI
IL-10 Receptor Signaling That Regulates Innate Immunity$417,578
R01 · FY2008 · AI · contact PI
The Molecular and Cellular Basis of Cancer Immunoediting$406,115
R01 · FY2008 · CA · contact PI
Genetic Core$207,762
P30 · FY2008 · AR · contact PI
Tumor Immunology Program$53,431
P30 · FY2008 · CA · contact PI
Training in Cancer Biology$513,905
T32 · FY2007 · CA · contact PI
IL-10 Receptor Signaling That Regulates Innate Immunity$413,267
R01 · FY2007 · AI · contact PI
IFNgamma Receptor Signaling Dysfuction in Cancer$412,713
R01 · FY2007 · CA · contact PI
The Molecular and Cellular Basis of Cancer Immunoediting$404,231
R01 · FY2007 · CA · contact PI
Genetic Core$172,693
P30 · FY2007 · AR · contact PI
Tumor Immunology Program$55,977
P30 · FY2007 · CA · contact PI
Training in Cancer Biology$426,496
T32 · FY2006 · CA · contact PI
IFNgamma Receptor Signaling Dysfuction in Cancer$415,578
R01 · FY2006 · CA · contact PI
IL-10 Receptor Signaling That Regulates Innate Immunity$413,213
R01 · FY2006 · AI · contact PI
The Molecular and Cellular Basis of Cancer Immunoediting$406,377
R01 · FY2006 · CA · contact PI
TRAINING IN CANCER BIOLOGY$510,371
T32 · FY2005 · CA
The Molecular and Cellular Basis of Cancer Immunoediting$479,872
R01 · FY2005 · CA
IFNgamma Receptor Signaling Dysfuction in Cancer$416,169
R01 · FY2005 · CA
IL-10 Receptor Signaling That Regulates Innate Immunity$410,112
R01 · FY2005 · AI
IFNgamma Receptor Signaling Dysfuction in Cancer$407,037
R01 · FY2004 · CA
IL-10 Receptor Signaling That Regulates Innate Immunity$398,874
R01 · FY2004 · AI
The Molecular and Cellular Basis of Cancer Immunoediting$395,035
R01 · FY2004 · CA
Tumor Immunology Program$20,302
P30 · FY2004 · CA
Jaks and Stats: Development to Disease$10,000
R13 · FY2004 · CA
MOLECULAR MECHANISMS OF IMMUNE EVASION BY TUMORS$1,101,535
P01 · FY2003 · CA
Training Program in Immunology and Immunogenetics$695,277
T32 · FY2003 · AI
IFNgamma Receptor Signaling Dysfuction in Cancer$398,167
R01 · FY2003 · CA
MOLECULAR MECHANISMS OF IMMUNE EVASION BY TUMORS$1,073,274
P01 · FY2002 · CA
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS$816,541
T32 · FY2002 · AI
MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITY$393,388
R37 · FY2002 · CA
INTERFERON GAMMA SIGNALING DEFECTS IN TUMOR EVASION$199,030
P01 · FY2002 · CA
TUMOR IMMUNOLOGY$0
P30 · FY2002 · CA
CORE--GENETIC$0
P30 · FY2002 · AR
MOLECULAR MECHANISMS OF IMMUNE EVASION BY TUMORS$1,045,559
P01 · FY2001 · CA
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS$750,307
T32 · FY2001 · AI
MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITY$386,405
R37 · FY2001 · CA
INTERFERON GAMMA SIGNALING DEFECTS IN TUMOR EVASION$199,030
P01 · FY2001 · CA
TUMOR IMMUNOLOGY$0
P30 · FY2001 · CA
CORE--GENETIC$0
P30 · FY2001 · AR
MOLECULAR MECHANISMS OF IMMUNE EVASION BY TUMORS$1,093,181
P01 · FY2000 · CA
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS$807,338
T32 · FY2000 · AI
MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITY$381,560
R37 · FY2000 · CA
INTERFERON GAMMA SIGNALING DEFECTS IN TUMOR EVASION$199,030
P01 · FY2000 · CA